How effective is prevention in coronary heart disease?

Heart

Volumn 94, Issue 11, 2008, Pages 1370-1371

  Cupples, Margaret E ^a   Smith, Susan M ^b   Murphy, Andrew W ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE COST; HEALTH SERVICE; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; STATISTICS; SURVIVAL;

AGED; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; PRIMARY PREVENTION;

EID: 54349095024     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.133777     Document Type: Editorial

References (14)

1. Delaney EK, Murchie P, Lee AJ, et al. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care. Heart 2008;94:1419-23.
2. Campbell NC, Murray E, Darbyshire J, et al. Designing and evaluating complex interventions to improve health care. BMJ 2007;334:455-9.
3. Buckley B, Murphy AW, Byrne M, et al. Selection bias resulting from the requirement for prior consent in observational research: a community cohort of people with ischaemic heart disease. Heart 2007;93:1116-20.
4. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7.
5. Bennett K, Kabir Z, Unal B, et al. Explaining the recent decrease in coronary heart mortality rates in Ireland, 1985-2000. J Epidemiol Community Health 2006;60:3222-7.
6. Ebrahim S, Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997;314:1666-74.
7. Manuel DG, Lim J, Tanuseputro P, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006;332:659- 62.
8. McAlister FA, Lawson FME, Teo KK, et al. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62.
9. Jolly K, Bradley F, Sharp S, et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 1999;318:706-11.
10. Hulscher M, Wensing M, van der Weijen T, et al. Interventions to implement prevention in primary care. Cochrane Database Sys Rev 2001;(1):CD000362.
11. Raftery JP, Guiping LY, Murchie P, et al. Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial. BMJ 2005;330:707-10.
12. O'Neill C, Normand C, Cupples M, et al. Cost effectiveness of personal health education for people with angina in the Greater Belfast area of Northern Ireland. J Epidemiol Community Health 1996;50:538-40.
13. Byrne M, Cupples ME, Smith SM, et al. Development of a complex intervention for secondary prevention of coronary heart disease in primary care using the Medical Research Council framework. Am J Manag Care 2006;12:261-6.
14. Guthrie B, Inkster M, Fahey T. Tackling therapeutic inertia: role of treatment data in quality indicators. BMJ 2007;335:542-4.